148 related articles for article (PubMed ID: 28903776)
1. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes.
Baba H; Kurano M; Nishida T; Hatta H; Hokao R; Tsuneyama K
BMC Res Notes; 2017 Sep; 10(1):478. PubMed ID: 28903776
[TBL] [Abstract][Full Text] [Related]
2. Neonatal streptozotocin treatment rapidly causes different subtype of hepatocellular carcinoma without persistent hyperglycemia in 4CS mice fed on a normal diet.
Kobayashi T; Ichimura-Shimizu M; Oya T; Ogawa H; Matsumoto M; Morimoto Y; Sumida S; Kakimoto T; Yamashita M; Sutoh M; Toyohara S; Hokao R; Cheng C; Tsuneyama K
Pathol Res Pract; 2021 Sep; 225():153559. PubMed ID: 34325313
[TBL] [Abstract][Full Text] [Related]
3. Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet.
Baba H; Tsuneyama K; Nishida T; Hatta H; Nakajima T; Nomoto K; Hayashi S; Miwa S; Nakanishi Y; Hokao R; Imura J
Hepatol Int; 2014 Jul; 8(3):415-24. PubMed ID: 26202643
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperglycemia on hepatocellular carcinoma development in diabetes.
Niwa Y; Ishikawa K; Ishigami M; Honda T; Achiwa K; Izumoto T; Maekawa R; Hosokawa K; Iida A; Seino Y; Hamada Y; Goto H; Oiso Y; Arima H; Tsunekawa S
Biochem Biophys Res Commun; 2015 Jul; 463(3):344-50. PubMed ID: 26022129
[TBL] [Abstract][Full Text] [Related]
5. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
6. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
[TBL] [Abstract][Full Text] [Related]
7. A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment.
Podell BK; Ackart DF; Richardson MA; DiLisio JE; Pulford B; Basaraba RJ
Dis Model Mech; 2017 Feb; 10(2):151-162. PubMed ID: 28093504
[TBL] [Abstract][Full Text] [Related]
8. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
10. Effect of insufficient insulin treatment in streptozotocin-induced diabetes mellitus.
Ozmen O; Topsakal S; Sahinduran S; Ozcelik M
Pancreas; 2007 Apr; 34(3):354-8. PubMed ID: 17414059
[TBL] [Abstract][Full Text] [Related]
11. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma].
Luo Y; Yang WJ; Chen JY; Zhang J; Zeng XD; Zhuang ZJ; Zang SF; Zhou G; Di CH; Shi JP
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):279-84. PubMed ID: 27470627
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract.
Patil MA; Suryanarayana P; Putcha UK; Srinivas M; Reddy GB
Oxid Med Cell Longev; 2014; 2014():463264. PubMed ID: 25505935
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.
Skovsø S; Damgaard J; Fels JJ; Olsen GS; Wolf XA; Rolin B; Holst JJ
Int J Obes (Lond); 2015 Oct; 39(10):1531-8. PubMed ID: 26121961
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis.
Kojima M; Takahashi H; Kuwashiro T; Tanaka K; Mori H; Ozaki I; Kitajima Y; Matsuda Y; Ashida K; Eguchi Y; Anzai K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785012
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Insulin Attenuates the Long-Term Adverse Effects of Neonatal Hyperglycemia on the Hippocampus in Rats.
McClure Yauch L; Ennis-Czerniak K; Frey Ii WH; Tkac I; Rao RB
Dev Neurosci; 2022; 44(6):590-602. PubMed ID: 36041414
[TBL] [Abstract][Full Text] [Related]
17. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
Abdollahi M; Zuki AB; Goh YM; Rezaeizadeh A; Noordin MM
Histol Histopathol; 2011 Jan; 26(1):13-21. PubMed ID: 21117023
[TBL] [Abstract][Full Text] [Related]
18. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
19. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
20. Effect of neonatal streptozotocin and thyrotropin-releasing hormone treatments on insulin secretion in adult rats.
Bacová Z; Najvirtová M; Krizanová O; Hudecová S; Zórad S; Strbák V; Benický J
Gen Physiol Biophys; 2005 Jun; 24(2):181-97. PubMed ID: 16118471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
